Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease-Reference-Cited by-同舟云学术

Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease

Published:2020-03-09 Issue:5 Volume:29 Page:591-598
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Gungabissoon Usha¹^ORCID,Kirichek Oksana²,El Baou Céline²,Galwey Nicholas³

Affiliation:

1. Department of EpidemiologyGlaxoSmithKline (GSK) R&D Uxbridge UK

2. Real World Data AnalyticsGSK R&D Uxbridge UK

3. Medicines Research Centre StevenageGSK R&D Hertfordshire UK

Funder

SmithKline Beecham Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4986

Reference32 articles.

1. The epidemiology of Parkinson's disease: risk factors and prevention

2. Pharmacological Treatment of Parkinson Disease

3. Parkinson's disease in adults. NICE guideline published: July 19 2017https://www.nice.org.uk/guidance/ng71/resources/parkinsons-disease-in-adults-pdf-1837629189061. Accessed on July 31 2018.

4. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

5. Impulse Control Disorders in Parkinson Disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-07-24

2. Opicapone versus entacapone: Head‐to‐head retrospective data‐based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol‐O‐methyltransferase (COMT) inhibitor treatment;European Journal of Neurology;2023-08-19

3. Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan;Drugs - Real World Outcomes;2020-10-16

4. Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2020-08-17